RhumbLine Advisers’s CytRx Corp CYTR Stock Holding History

RhumbLine Advisers’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-20,060	Closed	-$53K	–	3039
2017 Q1	$53K	Buy	20,060 +9,990	+99%	+$25.3K	﹤0.01%	2819
2016 Q4	$22K	Sell	10,070 -4,807	-32%	-$14.1K	﹤0.01%	2843
2016 Q3	$52K	Buy	14,877 +140	+0.9%	+$641	﹤0.01%	2850
2016 Q2	$197K	Buy	14,737 +4,088	+38%	+$68K	﹤0.01%	2749
2016 Q1	$171K	Buy	10,649 +87	+0.8%	+$1.19K	﹤0.01%	2784
2015 Q4	$168K	Buy	10,562 +1,003	+10%	+$17.2K	﹤0.01%	2858
2015 Q3	$136K	Buy	9,559 +958	+11%	+$16.2K	﹤0.01%	2894
2015 Q2	$192K	Sell	8,601 -3,404	-28%	-$85.2K	﹤0.01%	2905
2015 Q1	$243K	Buy	12,005 +933	+8%	+$17.4K	﹤0.01%	2730
2014 Q4	$182K	Buy	11,072 +863	+8%	+$13.5K	﹤0.01%	2848
2014 Q3	$156K	Hold	10,209	–	–	﹤0.01%	2842
2014 Q2	$256K	Buy	+10,209	New	+$233K	﹤0.01%	2692

Other funds holding CYTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RhumbLine Advisers's CYTR Position: Q2 2017 in Review

RhumbLine Advisers sold out of CytRx Corp (CYTR) in Q2 2017, closing a stake of 20,060 shares — an estimated $53K sold.

RhumbLine Advisers first reported a position in CYTR in Q2 2014 and held it in 12 quarters. The position peaked at $256K in Q2 2014. 54 funds tracked by Wall St. Rank hold CYTR as of Q2 2017.

RhumbLine Advisers reported no remaining CytRx Corp position as of Q2 2017 after selling out during the quarter.
RhumbLine Advisers sold 20,060 CytRx Corp shares in Q2 2017, an estimated $53K.
RhumbLine Advisers first reported a position in CytRx Corp in Q2 2014 and held it in 12 quarters.
RhumbLine Advisers's CytRx Corp position peaked at $256K in Q2 2014.
54 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2017.

Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.